Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by jojomarchon Dec 31, 2019 3:05pm
154 Views
Post# 30506565

Trial results

Trial resultsTLT is gathering efficacy data @day-7, 30, 60, 90, 180, 187, 210, 240, 270 and 360 ... They could prove that it is way more efficient than BCG, complicating life of urologists that would be directed to keep using BCG

If the 90 day results and 180 day results  are both CR then  , using common sense , the subsequent results are guaranteed because of the retreatment . Having P5 and P6 go beyond 540 days is no fluke and now with the PH2 trials being highly selective  ( if some cancer cells are located in the urinary tract you can't participate in the trial ) . Fireworks are flying all over the place for the new year ....the TLT fireworks will fly this year . Congratulations to all longs and especially to the patients being treated now and in the future with this groundbreaking technology .

LONG LIFE AND HAPPY NEW YEAR
Bullboard Posts